* Aethlon Medical Inc AEMD.OQ AEMD.O is expected to show
a
fall in quarterly revenue when it reports results on November
14.
* The San Diego California-based company is expected to
report a
47.3% decrease in revenue to $69.5 thousand from $131.97
thousand a year ago, according to the mean estimate from 2
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Aethlon Medical Inc
is
for a loss of 21 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Aethlon
Medical
Inc is $8, above its last closing price of $0.50.
This summary was machine generated November 12 at 03:04 GMT.
All figures in US dollars unless otherwise stated